Contact us

Thank you for your interest in Garg Law PLLC.

Our commitment to understanding your regulatory questions and business goals, and helping you achieve results starts here.

If you are looking for representation on a new matter, please fill out the form below to request a free consultation. The form enables us to conduct a preliminary check for potential conflicts of interest and to determine if we can proceed with the free consultation.

CORE Outbreak Investigation Table

The CORE Outbreak Investigation Table is a list of outbreak and adverse event investigations primarily being managed by FDA’s CORE Response Teams. The investigations are in a variety of stages, meaning that some outbreaks have limited information, and others may be near completion. The table will be updated weekly.

This week’s updates are: 

  • A new outbreak of Salmonella Africana (ref #1351) has been added to the table. FDA has initiated traceback.
  • For the outbreak of Salmonella Saintpaul (ref #1353) the case count has increased from 44 to 50. 
  • For the outbreak of Salmonella Richmond (ref #1345) linked to moringa leaf powder, FDA updated the advisory to share final investigational updates. CDC has declared that the outbreak is over. 

The following investigations are now closed:  

  • For the outbreak of Salmonella Lomalinda (ref #1339) linked to spring mix, FDA’s investigation is closed. Based on CDC’s epidemiological investigation, ill people reported eating spring mix before becoming sick. CDC, FDA, and state and local partners conducted epidemiologic and traceback investigations, and collected and analyzed product and environmental samples. All samples collected as part of the investigation were reported as negative for Salmonella. Once investigators had enough information to confirm spring mix as the source of this outbreak, the outbreak was no longer considered ongoing, and the spring mix was past shelf life and not available for sale. This outbreak is over, and there is no ongoing risk to public health.  
  • For the outbreak of Listeria monocytogenes (ref #1334) linked to a not identified product, FDA’s investigation is closed. 
  • For the outbreak of Salmonella Enteritidis (ref #1329) linked to a not identified product, FDA’s investigation is closed. 
  • For the outbreak of Cyclospora cayetanensis (ref #1325) linked to parsley, FDA’s investigation is closed. Based on CDC’s epidemiological investigation, ill people reported eating food items or dishes that contained parsley before becoming sick. CDC, FDA, and state and local partners conducted epidemiologic and traceback investigations, and collected and analyzed product and environmental samples. All samples collected as part of the investigation were reported as negative for Cyclospora. Investigators confirmed parsley as the likely source of this outbreak. The parsley linked to illnesses was past shelf life and not available for sale. This outbreak is over, and there is no ongoing risk to public health.  
  • For the outbreak of Cyclospora cayetanensis (ref #1313) linked to a not identified product, the case count has been adjusted from 47 to 48. FDA’s investigation is closed.

    CORE Outbreak Investigation Table
Request a Consultation

★★★★★

Working with Shelly on various new product launches over the last couple of years has been seamless. Quick and clear guidance is always what we get.
R.G. Client
I've been working with Shelly and her team at Garg law for a little while now and they are fantastic! Very responsive, professional and they certainly get things done. Extremely satisfied with their service and highly recommend.
Mike H. Client
Ms Garg helped my company navigate an FDA import issue. She achieved an excellent result, was very responsive and professional, and managed to keep the project within budget. She is a stellar attorney.
Dr. Sastry Client
I have been using Shelly Garg as FDA Counsel for 10+ years, since she was at another international law firm. While we continued to use the previous firm she was at (mainly due to the process required to change firms), we realized the quality of counsel was not the same. We have since been using Garg Law and the ease of use and trust in the knowledge was back instantly. Shelly has the skills to help me understand the regulations (by translating into layman's terms) and risks in a manner that is specific to my business. She is also extremely timely in her responses which is critical when we have a deadline mandated by the FDA. Many other attorneys cite the regulations which l've already read, but need further counsel. In my opinion, this demonstrates Shelly's in-depth knowledge of the regulations, how they pertain to the law, and how they are applicable IRL. Shelly's personable approach and pleasant manner in communication makes it very easy to have been work with her and have productive discussions on the best next steps. She truly has a passion iternational for all things FDA and I've learned so much from her.
Claire P. Client

News & Insights

Get the latest news on FDA regulatory delivered straight to your inbox.